These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2527270)

  • 1. Effect of membrane phospholipids on activation of the alternative complement pathway.
    Mold C
    J Immunol; 1989 Sep; 143(5):1663-8. PubMed ID: 2527270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of gangliosides on activation of the alternative pathway of human complement.
    Michalek MT; Bremer EG; Mold C
    J Immunol; 1988 Mar; 140(5):1581-7. PubMed ID: 3346542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.
    Mold C; Kingzette M; Gewurz H
    J Immunol; 1984 Aug; 133(2):882-5. PubMed ID: 6234363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor.
    Mold C; Walter EI; Medof ME
    J Immunol; 1990 Dec; 145(11):3836-41. PubMed ID: 1700997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the alternative pathway of complement by cellulosic hemodialysis membranes.
    Cheung AK; Parker CJ; Wilcox L; Janatova J
    Kidney Int; 1989 Aug; 36(2):257-65. PubMed ID: 2528653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
    Kazatchkine MD; Fearon DT; Silbert JE; Austen KF
    J Exp Med; 1979 Nov; 150(5):1202-15. PubMed ID: 501288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of human complement by liposomes: a model for membrane activation of the alternative pathway.
    Cunningham CM; Kingzette M; Richards RL; Alving CR; Lint TF; Gewurz H
    J Immunol; 1979 Apr; 122(4):1237-42. PubMed ID: 448089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
    J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the alternative complement pathway of guinea-gip by liposomes incorporated with trinitrophenylated phosphatidylethanolamine.
    Okada N; Yasuda T; Tsumita T; Okada H
    Immunology; 1982 Jan; 45(1):115-24. PubMed ID: 6173312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the alternative pathway of complement by calcium-loaded erythrocytes resulting from loss of membrane phospholipid asymmetry.
    Test ST; Mitsuyoshi J
    J Lab Clin Med; 1997 Aug; 130(2):169-82. PubMed ID: 9280144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation in sickle cell disease: a liposome model.
    Tomasko MA; Chudwin DS
    J Lab Clin Med; 1988 Aug; 112(2):248-53. PubMed ID: 2969403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups on nonactivating surfaces.
    Carreno MP; Labarre D; Maillet F; Jozefowicz M; Kazatchkine MD
    Eur J Immunol; 1989 Nov; 19(11):2145-50. PubMed ID: 2480904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary recognition of alternative pathway activators by decay-accelerating factor and factor H.
    Kraus D; Medof ME; Mold C
    Infect Immun; 1998 Feb; 66(2):399-405. PubMed ID: 9453587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of factor H by heparin: a rate-limiting mechanism for inhibition of the alternative complement pathway.
    Boackle RJ; Caughman GB; Vesely J; Medgyesi G; Fudenberg HH
    Mol Immunol; 1983 Nov; 20(11):1157-64. PubMed ID: 6228720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
    Kozel TR; Wilson MA; Pfrommer GS; Schlageter AM
    Infect Immun; 1989 Jul; 57(7):1922-7. PubMed ID: 2525113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
    Brown EJ; Joiner KA; Gaither TA; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of resistance to lysis by the alternative complement pathway in Trypanosoma cruzi trypomastigotes: effect of specific monoclonal antibody.
    Schenkman S; Güther ML; Yoshida N
    J Immunol; 1986 Sep; 137(5):1623-8. PubMed ID: 2943798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients.
    Wang RH; Phillips G; Medof ME; Mold C
    J Clin Invest; 1993 Sep; 92(3):1326-35. PubMed ID: 7690777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal glycoprotein activates the alternative complement pathway by reacting with factor H.
    Winsnes R; Lachmann PJ
    Scand J Immunol; 1982 Apr; 15(4):371-8. PubMed ID: 6213029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement.
    Kew RR; Ghebrehiwet B; Janoff A
    J Clin Invest; 1985 Mar; 75(3):1000-7. PubMed ID: 3156879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.